Cargando…

Identification of novel SCD1 inhibitor alleviates nonalcoholic fatty liver disease: critical role of liver-adipose axis

Due to the complexity and incomplete understanding of the crosstalk between liver and adipose tissue, especially the processes of hepatic lipogenesis and adipogenic differentiation, there are currently no effective drugs for the treatment of nonalcoholic fatty liver disease (NAFLD). Stearoyl-coenzym...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Wei, Kong, Yulin, Wang, Xia, Wang, Zhe, Tang, Chunlei, Li, Jinyou, Yang, Qin, Chen, Yong Q., Zhu, Shenglong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544195/ https://www.ncbi.nlm.nih.gov/pubmed/37777801 http://dx.doi.org/10.1186/s12964-023-01297-9

Ejemplares similares

Lycium ruthenicum Murr. alleviates nonalcoholic fatty liver in mice
por: Lu, Keke, et al.
Publicado: (2020)

Bile Acid Receptors and the Gut–Liver Axis in Nonalcoholic Fatty Liver Disease
por: Xue, Rui, et al.
Publicado: (2021)

Hydrogen inhalation alleviates nonalcoholic fatty liver disease in metabolic syndrome rats
por: Liu, Boyan, et al.
Publicado: (2020)

Dexmedetomidine ameliorates high‐fat diet‐induced nonalcoholic fatty liver disease by targeting SCD1 in obesity mice
por: Tao, Linfen, et al.
Publicado: (2020)

Zhuyu Pill Alleviates Nonalcoholic Fatty Liver Disease by Regulating Bile Acid Metabolism through the Gut–Liver Axis
por: Xu, Lu, et al.
Publicado: (2023)

The Role of Olfactomedin 2 in the Adipose Tissue–Liver Axis and Its Implication in Obesity-Associated Nonalcoholic Fatty Liver Disease
por: Barrientos-Riosalido, Andrea, et al.
Publicado: (2023)

Gut-liver axis modulation of Panax notoginseng saponins in nonalcoholic fatty liver disease
por: Xu, Yu, et al.
Publicado: (2021)

Macronutrients and the Adipose-Liver Axis in Obesity and Fatty Liver
por: Duwaerts, Caroline C., et al.
Publicado: (2019)

Effect of Probiotics Therapy on Nonalcoholic Fatty Liver Disease
por: Huang, Yuanshe, et al.
Publicado: (2022)

Combined Use of Bicyclol and Berberine Alleviates Mouse Nonalcoholic Fatty Liver Disease
por: Li, Hu, et al.
Publicado: (2022)

White Adipose Tissue Autophagy and Adipose-Liver Crosstalk Exacerbate Nonalcoholic Fatty Liver Disease in Mice
por: Sakane, Sadatsugu, et al.
Publicado: (2021)

Periodontal disease–related nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: An emerging concept of oral‐liver axis
por: Kuraji, Ryutaro, et al.
Publicado: (2021)

Icariin Alleviates Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome by Improving Liver Fatty Acid Oxidation and Inhibiting Lipid Accumulation
por: Hai, Yang, et al.
Publicado: (2023)

Celecoxib alleviates nonalcoholic fatty liver disease by restoring autophagic flux
por: Liu, Cong, et al.
Publicado: (2018)

Hepatic Stearoyl-CoA Desaturase (SCD)-1 Activity and Diacylglycerol but Not Ceramide Concentrations Are Increased in the Nonalcoholic Human Fatty Liver
por: Kotronen, Anna, et al.
Publicado: (2009)

Osteocalcin Alleviates Nonalcoholic Fatty Liver Disease in Mice through GPRC6A
por: Zhang, Mingliang, et al.
Publicado: (2021)

Atractylodin alleviates nonalcoholic fatty liver disease by regulating Nrf2-mediated ferroptosis
por: Ye, Qingyan, et al.
Publicado: (2023)

Liver fatty acid composition in mice with or without nonalcoholic fatty liver disease
por: Wang, Xin, et al.
Publicado: (2011)

The hepatic integrated stress response suppresses the somatotroph axis to control liver damage in nonalcoholic fatty liver disease
por: Ohkubo, Rika, et al.
Publicado: (2022)

Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease
por: Bebawi, Emmanuel, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease stratification by liver lipidomics
por: Vvedenskaya, Olga, et al.
Publicado: (2021)

Epicardial Adipose Tissue (EAT) Thickness Is Associated with Cardiovascular and Liver Damage in Nonalcoholic Fatty Liver Disease
por: Fracanzani, Anna Ludovica, et al.
Publicado: (2016)

Volatile Oil of Amomum villosum Inhibits Nonalcoholic Fatty Liver Disease via the Gut-Liver Axis
por: Lu, Shanhong, et al.
Publicado: (2018)

Nonalcoholic Fatty Liver Disease Impairs the Liver–Alpha Cell Axis Independent of Hepatic Inflammation and Fibrosis
por: Pedersen, Julie Steen, et al.
Publicado: (2020)

Intervention of Shugan Xiaozhi Decoction on Nonalcoholic Fatty Liver Disease via Mediating Gut-Liver Axis
por: Yang, Huili, et al.
Publicado: (2022)

The role of microbiome in the pathogenesis of oral-gut-liver axis between periodontitis and nonalcoholic fatty liver disease
por: Chen, Tsung-Po, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease after Liver Transplant
por: Shetty, Akshay, et al.
Publicado: (2021)

Nonalcoholic fatty liver disease and non-liver comorbidities
por: Manikat, Richie, et al.
Publicado: (2023)

Peroxisome Proliferator-Activated Receptors Associated with Nonalcoholic Fatty Liver Disease
por: Wang, Nan, et al.
Publicado: (2017)

Visceral Adipose Tissue Area as an Independent Risk Factor for Elevated Liver Enzyme in Nonalcoholic Fatty Liver Disease
por: Chung, Goh Eun, et al.
Publicado: (2015)

Characterization of adipose tissue-derived stromal cells of mice with nonalcoholic fatty liver disease and their use for liver repair
por: Yano, Masaaki, et al.
Publicado: (2021)

Considerations for Physiologically Based Modeling in Liver Disease: From Nonalcoholic Fatty Liver (NAFL) to Nonalcoholic Steatohepatitis (NASH)
por: Murphy, William A., et al.
Publicado: (2022)

Cholic Acid Enhances Visceral Adiposity, Atherosclerosis and Nonalcoholic Fatty Liver Disease in Microminipigs
por: Yamada, Sohsuke, et al.
Publicado: (2017)

Diabetes and Nonalcoholic Fatty Liver Disease
por: Kantartzis, Konstantinos, et al.
Publicado: (2012)

Probiotics and Nonalcoholic Fatty liver Disease
por: Eslamparast, Tannaz, et al.
Publicado: (2013)

Sirtuins and nonalcoholic fatty liver disease
por: Nassir, Fatiha, et al.
Publicado: (2016)

History of Nonalcoholic Fatty Liver Disease
por: Lonardo, Amedeo, et al.
Publicado: (2020)

Nonalcoholic fatty liver disease and diabetes
por: Bellini, Maria Irene, et al.
Publicado: (2022)

Circulating Citrate Is Associated with Liver Fibrosis in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
por: Amjad, Waseem, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f88ciag04j1sgu5ebkohk3brv0